Generalized osteoporosis in non-steroid treated rheumatoid arthritis
- PMID: 1947672
- DOI: 10.1007/BF00291149
Generalized osteoporosis in non-steroid treated rheumatoid arthritis
Abstract
To investigate the presence of reduced bone mineral density (BMD) and to assess determinants of bone loss in rheumatoid arthritis, 45 female patients suffering from non-steroid treated rheumatoid arthritis were submitted to dual photon absorptiometry of the lumbar spine and to laboratory tests for calcium metabolism. The rheumatoid arthritis patients were divided into two groups according to anatomic grade and functional class; no abnormalities in calcium metabolism were detected whereas BMD was significantly lower in the third and fourth grade and in the third and fourth class patients (P less than 0.005 versus controls, versus grades I and II and versus classes 1 and 2). BMD was significantly correlated with age (P less than 0.001) and years postmenopausal (P less than 0.01), but not with duration of disease. By multiple linear regression we derived an equation predictive of BMD. Osteoporosis in rheumatoid arthritis is observed even in non-corticosteroid treated patients; articular lesions with subsequent reduction in physical activity appear to play an important role in axial bone loss in rheumatoid arthritis.
Similar articles
-
A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis.J Rheumatol. 2000 Nov;27(11):2582-9. J Rheumatol. 2000. PMID: 11093437
-
The development of bone mineral density and the occurrence of osteoporosis from 15 to 20 years of disease onset in patients with rheumatoid arthritis.Clin Exp Rheumatol. 2005 Mar-Apr;23(2):193-8. Clin Exp Rheumatol. 2005. PMID: 15895889
-
Bone mineral density and frequency of osteoporosis among Vietnamese women with early rheumatoid arthritis.Clin Rheumatol. 2011 Oct;30(10):1353-61. doi: 10.1007/s10067-011-1762-x. Epub 2011 May 6. Clin Rheumatol. 2011. PMID: 21547438
-
Osteoporosis associated with rheumatoid arthritis: pathogenesis and management.Semin Arthritis Rheum. 1991 Feb;20(4):256-72. doi: 10.1016/0049-0172(91)90021-q. Semin Arthritis Rheum. 1991. PMID: 2042057 Review.
-
[Osteoporosis in rheumatoid arthritis].Nihon Rinsho. 1992 Mar;50(3):592-6. Nihon Rinsho. 1992. PMID: 1588754 Review. Japanese.
Cited by
-
Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis--a population based study.Ann Rheum Dis. 1994 Jan;53(1):18-23. doi: 10.1136/ard.53.1.18. Ann Rheum Dis. 1994. PMID: 8311549 Free PMC article.
-
Relation of interleukin-6 in rheumatoid arthritis patients to systemic bone loss and structural bone damage.Rheumatol Int. 2013 Mar;33(3):697-703. doi: 10.1007/s00296-012-2375-7. Epub 2012 Apr 25. Rheumatol Int. 2013. PMID: 22531887
-
Bone mineral density in nonsteroid treated early rheumatoid arthritis.Ann Rheum Dis. 1994 Oct;53(10):681-4. doi: 10.1136/ard.53.10.681. Ann Rheum Dis. 1994. PMID: 7979582 Free PMC article.
-
Theoretical relationship between maximum pore size and toughness in experimental inflammatory arthritis.J Mater Sci Mater Med. 2000 May;11(5):313-8. doi: 10.1023/a:1008913501297. J Mater Sci Mater Med. 2000. PMID: 15348029
-
A risk-benefit assessment of slow-acting antirheumatic drugs in rheumatoid arthritis.Drug Saf. 1994 Jul;11(1):21-36. doi: 10.2165/00002018-199411010-00004. Drug Saf. 1994. PMID: 7917079 Review.
References
MeSH terms
Substances
LinkOut - more resources
Medical